QSI

$0.93

Post-MarketAs of Mar 17, 8:00 PM UTC

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS).

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$0.93
Potential Upside
5%
Whystock Fair Value$0.98
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instrument...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$201.27M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
3.08
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-46.52%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
7.33

Recent News

Moby
Mar 4, 2026

Quantum-Si incorporated Q4 2025 Earnings Call Summary

Moby summary of Quantum-Si incorporated's Q4 2025 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
GuruFocus.com
Mar 4, 2026

Quantum-Si Inc (QSI) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges

Quantum-Si Inc (QSI) showcases technological progress and strategic planning despite facing revenue and profitability pressures.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Motley Fool
Mar 3, 2026

Quantum-Si (QSI) Q4 2025 Earnings Call Transcript

Joining me today are Jeffrey Hawkins, our President and Chief Executive Officer, as well as Jeffry R. Keyes, our Chief Financial Officer. As a reminder, during 2025, we announced the launch of an expanded set of instrument acquisition options that allow customers to have our instrument in their lab and purchase and run consumables without having to find the capital dollars to acquire the instrument upfront.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 3, 2026

Quantum-Si Q4 Earnings Call Highlights

Quantum-Si (NASDAQ:QSI) reported fourth-quarter and full-year 2025 results and outlined a “transition year” outlook for 2026, as management said it plans to prioritize development and commercial readiness for the Proteus platform ahead of an expected launch at the end of 2026. 2026 positioned as a

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jan 5, 2026

Quantum-Si (NASDAQ:QSI) shareholders have endured a 89% loss from investing in the stock five years ago

We're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...

BEARISH
Negative press. News cycle fixated on risk factors or misses.